Vima Therapeutics, VIM0423, Dystonia, Isolated Dystonia, Parkinson’s Disease, Movement Disorders, Muscarinic Receptors, M4 Receptor, Acetylcholine, Dopamine, Neurology,

BOSTON, Mass. — October 1, 2026 Vima Therapeutics announced that it will present four research posters at the 2026...